Wang et al., have reported that EGFR inhibitors are capable of rescuing the Aβ-induced memory loss in both transgenic fruit fly and transgenic mouse models and have suggested that inhibition of Aβ-induced EGFR activation might be an effective way to treat Aβ-induced memory loss in AD. This evidence concerns the gene EGFR and Alzheimer disease.